Tag: MS

“Symptoms, then, are in reality nothing but a cry from suffering organs” – Jean-Martin Charcot Nearly 130 years after his death, Jean-Martin Charcot’s name still resonates with modern neurologists. The famed 19th century French physician made myriad enduring contributions to the field. His eponymous foot condition might be his best known. He also delved into

Selma Blair opened up about undergoing chemotherapy for multiple sclerosis at the Time 100 Health Summit. The actress revealed she and her son planned for her death before starting chemo. Selma says she “had more chemo than they usually do for cancer patients, because they almost kill you.” Selma Blair, 47, has been super open

Understanding and mitigating the role of epigenetics (environmental influences that trigger changes in gene expression) in disease development is a major goal of researchers. Now, a newly published paper featured on the March cover of the journal Brain adds significantly to this work by detailing how metabolites can be used to inhibit epigenetic mechanisms and

Two days after her triumphant return to the red carpet Opens a New Window. at the Vanity Fair Oscar Party on Sunday, February 24, cane in hand, Selma Blair Opens a New Window. marked another milestone: Her first on-camera interview after her diagnosis with multiple sclerosis, or MS. Blair sat down with Good Morning America

(HealthDay)—From 2005 to 2014, trends in palliative care use increased substantially among multiple sclerosis (MS) inpatients, according to a study published in the December issue of the Journal of Clinical Neuroscience. Yong-Jae Lee, Ph.D., from the Yonsei University College of Medicine in Seoul, South Korea, and colleagues used data from the 2005 to 2014 U.S.

For most people, it’s better to start taking drugs for multiple sclerosis (MS) early on rather than letting the disease run its course, according to a new guideline for treating MS from the American Academy of Neurology. The guideline is published in the April 23, 2018, online issue of Neurology, the medical journal of the

A Vanderbilt University Medical Center-led research team has shown that magnetic resonance imaging (MRI) can detect changes in resting-state spinal cord function in patients with multiple sclerosis (MS). This first application of these measures in patients living with MS, reported last week in the journal Brain, could lead to new ways to monitor the effectiveness

Researchers at Karolinska Institutet in Sweden have developed a new disease model for neurodegenerative diseases such as ALS and MS that can be used to develop new immunotherapies. The model is described in a publication in the scientific journal Nature Immunology. All of the body’s organs contain macrophages, which, as part of the immune system,